In the News

Share
1667 News Items found
scientific image of mouse lung cancer cells
Lung Cancer Cells’ ‘Memories’ Suggest New Strategy For Improving Treatment
Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.
Q&A
Dr. Helena Yu
Lung Cancer in Women and Nonsmokers: What To Know About Symptoms, Diagnosis, and Treatment
Learn about links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
Ming Li
How One Lab at MSK Is Working To Harness the Power of the Immune System Against Cancer
Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.
Dr. Michel Sadelain, Director of the Center for Cell Engineering, Sloan Kettering Institute.
Disrupting a Single Gene Could Improve CAR T Cell Immunotherapy, New Study Shows
Learn how disrupting a gene called SUV39H1 could make CAR T cells more powerful.
To our Community
A Message From Dr. Selwyn Vickers, MSK’s President and CEO
Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.
Antonio Lekhrajmal is seen outdoors with his wife, Maria. He has been successfully treated with checkpoint inhibitors for advanced stomach cancer.
How Checkpoint Inhibitors for Stage 4 Stomach Cancer Worked for Antonio
Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers.
Beatriz Galvan treasures spending time with her granddaughter, Mia Camila, after being successfully treated for breast cancer at MSK.
How MSK Is Improving Cancer Treatment for Hispanic Patients
Learn how MSK helps people facing cancer in every way they need, and understands the importance of speaking to patients in the language that provides them peace of mind.
How MSK Is Improving CAR-T Cell Therapy for Cancer Treatment
How MSK Is Improving CAR T Cell Therapy for Cancer Treatment
Learn how experts at MSK who helped develop CAR T cell therapy to fight cancer are making the treatment stronger, safer, more durable and accessible to more people.
Along with being a dedicated researcher, Dr. Chrysothemis Brown excels as a mentor to trainees like Gayathri Shibu (right).
Illuminating the Immune System
Learn how Dr. Chrysothemis Brown is shedding light on new types of immune cells and their role in cancer and other diseases.
MSK's Dr. Andrea Cercek greets John Bonito, Kelly Spill, and their newborn, Mya Grace.
It’s Personal: An MSK Doctor Meets a Patient’s Newborn Baby
Learn how a heralded clinical trial for rectal cancer led to Dr. Andrea Cercek of MSK meeting the 4-day-old newborn of her patient, who feared she could not get pregnant.
Claire’s Legacy
MSK Giving: Claire’s Legacy
Learn why an MSK patient is supporting the MSK mission with a bequest.
Immunotherapy is a powerful tool against cancer. How does it work? Who can it help? MSK expert Dr. Michael Postow has answers
Treating Cancer With Immunotherapy: FAQ
Learn the most frequently asked questions about immunotherapy, a form of cancer treatment that uses the body's own immune system to overpower cancer cells. Learn who it can help, how it works, and how experts at MSK are finding ways to make it benefit more people, including new combinations with other cancer treatments like chemotherapy, surgery, radiation and more.
MSK patient Guillaume Arnould  high fives with his son.
Treating Relapsed Multiple Myeloma With CAR T Cell Therapy Targeting GPRC5D
Learn how CAR T cell therapy and the expertise of MSK gave Guillaume Arnould another option for treating multiple myeloma, after other therapies failed.
Group of Black men posing at prostate cancer fundraising walk.
Annual Prostate Cancer Screening Pays Off for Black Community Leader in Harlem
A Black community leader seeks prompt treatment for prostate cancer, avoiding the harsh toll the disease often takes on men like him.
Breast cancer patient Natasha Bhalla meditates.
Helping People With Cancer Afford Food and Crucial Technology
Learn how MSK helps cancer patients in underserved communities with technology, food, language interpretation, and more. Natasha Bhalla, an MSK patient with breast cancer, talks about the difference it's made for her.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023
New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center
See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
MSK physician-scientist Vinod Balachandran.
New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Article
A research working in an MSK lab
MSK Research Highlights, October 19, 2023
New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.
Mijin Kim seen working in laboratory.
Advice From a ‘Wunderkind’: Why MSK Is Great for Early Career Researchers
Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.